Received grant in 2019

DCCC has funded 110,340 DKK to the project.

The largest variation and hence uncertainty in head and neck cancer radiotherapy, comes from the delineation of the target. The process and choice of imaging varies between the Danish Centres. The project group will organise a national multidisciplinary workshop to optimise and homogenise target delineation in head and neck cancer radiotherapy. The expected participants are experts from the departments of oncology as well as neuroradiologists and nuclear medicine specialists.

Multidisciplinary organisation
DAHANCA - the Danish Head and Neck Cancer Group 

Project stakeholders

• Kenneth Jensen, Consultant, Danish Centre for Particle Therapy and Associate Professor, Aarhus University. Primary contact, Mail: kennjens@rm.dk
• Jesper Grau Eriksen, Professor, Department of Oncology, Aarhus University Hospital
• Christian Rønn Hansen, Hospital Physicist, Department of Oncology, Odense University Hospital and Danish Centre for Particle Therapy
• Cai Grau, Professor, Consultant, Department of Oncology, Aarhus University Hospital

On behalf of the DAHANCA Radiotherapy Quality Assurance Group.

• Maria Andersen, MD, Aalborg University Hospital
• Martin S.Nielsen, physicist, Aalborg University Hospital
• Jørgen Johansen, MD, Odense University Hospital
• Jeppe Friborg, MD, Rigshospitalet
• Bob Smulders, physicist, Rigshospitalet
• Elo andersen, MD, Herlev Hospital
• Eva Samsøe, chief physicist, Sjælland University Hospital

Events
Workshop: Target delineation in head and neck cancer radiotherapy